Skip to main content
SpringerLink
Log in

Class II HLA Antigens in Benign and Malignant Lesions of Melanocytic Origin

  • Chapter
HLA Class II Antigens

Abstract

Following the unexpected detection of immunologically functional class II HLA antigens on melanoma cells in long–term culture [1, 2], several investigators have analyzed the expression of these antigens by surgically removed benign and malignant lesions of melanocytic origin [3–6]. These studies have been facilitated by the availability of monoclonal antibodies (MoAbs) which have contributed to the application of immunohistochemical techniques.

This work was supported by NIH grants A121384 and CA38469, by a grant from the Cancer Research Institute, NewYork, NY, USA, and by the Netherlands Foundation for the Fight against Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Winchester RJ, Wang CY, Gibofsky A, Kunkel HG, Lloyd KO, Old LJ (1978) Expression of class II HLA on cultured human malignant melanoma cell lines. Proc Natl Acad Sci USA 75:6235–6239

    Article  PubMed  CAS  Google Scholar 

  2. Wilson BS, Indiveri F, Pellegrino MA, Ferrone S (1979) DR (Ia–like) antigens on human melanoma cells. Serological detection and immunochemical characterisation. J Exp Med 148:658–668

    Article  Google Scholar 

  3. Natali PG, Cordiali Fei P, Cavaliere R, Di Filippo F, Quaranta V, Pellegrino MG, Ferrone S (1981) Class II HLA on freshly explanted human malignant melanoma. Detection with MoAb and correlation with clinical parameters. Clin Immunol Immuno–pathol 19:250–259

    Article  CAS  Google Scholar 

  4. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC Jr (1982) Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 129:2808–2815

    PubMed  CAS  Google Scholar 

  5. Thompson JJ, Herlyn MF, Elder DE, Clark WH, Steplewski Z, Koprowski H (1982) Use of MoAb in detection of melanoma-associated antigens in intact human tumors. Am J Pathol 107:357–361

    PubMed  CAS  Google Scholar 

  6. Thompson JJ, Herlyn MF, Elder DE, Clark WH, Steplewski Z, Koprowski H (1982) Expression of DR antigens in freshly frozen human tumors. Hybridoma 1:161–168

    Article  PubMed  CAS  Google Scholar 

  7. Ng AK, Pellegrino MA, Imai K, Ferrone S (1981) HLA-A,B antigens, class II HLA, and tumor associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with MoAb. J Immunol 127:443–447

    PubMed  CAS  Google Scholar 

  8. Quaranta V, Pellegrino MA, Ferrone S (1981) Serological and immunochemical characterization of the specificity of four MoAb to distinct determinants expressed on subpopulations of human class II HLA. J Immunol 125:548–665

    Google Scholar 

  9. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF (1979) Ia determinants on human T cell subsets defined by monoclonal antibodies: activation stimuli required for expression. J Exp Med 150:1472–1480

    Article  PubMed  CAS  Google Scholar 

  10. Lloyd KO, Ng J, Dippold WG (1981) Analysis of the biosynthesis of HLA–DR glycoproteins in human malignant melanoma cell lines. J Immunol 126:2408–2417

    PubMed  CAS  Google Scholar 

  11. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75:3405–3410

    Article  PubMed  CAS  Google Scholar 

  12. Acolla RS, Gross N, Carrel S, Corte G (1981) Distinct forms of both α and β subunits are present in the human Ia molecular pool. Proc Natl Acad Sci USA 78:4549–4551

    Article  Google Scholar 

  13. Bröcker EB, Suter L, Sorg C (1984) HLA–DR antigen expression in primary melanomas of the skin. J Invest Dermatol 82:244–247

    Article  PubMed  Google Scholar 

  14. Ghosh AK, Gatter KC, Mason DY (1984) Immunocytochemical characterization of monoclonal anti–HLA–DR antibodies. Dis Markers 2:223–233

    Google Scholar 

  15. Epenetos AA, Bobrow LG, Adams TE, Collins CM, Isaacson PG, Bodmer WF (1985) A monoclonal antibody that detects HLA–D region antigen in routinely fixed, wax embedded sections of normal and neoplastic lymphoid tissues. J Clin Pathol 38:12–17

    Article  PubMed  CAS  Google Scholar 

  16. Adams TE, Bodmer JG, Bodmer WF (1983) Production and characterization of monoclonal antibodies recognizing the α–chain subunits of human Ia alloantigens. Immunology 50:613–614

    PubMed  CAS  Google Scholar 

  17. Wilson BS, Herzig A, Lloyd RV (1984) Immunoperoxidase staining for Ia–like antigens in paraffin–embedded tissues from human melanoma and lung carcinoma. Am J Pathol 115:102–116

    PubMed  CAS  Google Scholar 

  18. Workshop on monoclonal antibodies to human MHC class II antigens (1984). Dis Markers 2:363–369

    Google Scholar 

  19. Crumpton MJ, Bodmer JG, Bodmer WF, Heyes JM, Lindsay J, Rudd CE (1984) Biochemistry of class II antigens: workshop report. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1984. Springer, Berlin Heidelberg New York Tokyo, pp 29–37

    Google Scholar 

  20. Quaranta V, Majdic O, Sintl G, Liszka K, Honigsmann H, Knapp W (1984) A human Ia cytoplastic determinant located on multiple forms of invariant chain (γ, γ2, γ3). J Immunol 132:1900–1905

    PubMed  CAS  Google Scholar 

  21. Natali PG, Segatto O, Ferrone S, Tosi R, Corte G (1984) Differential tissue distribution and ontogeny of DC–1 and HLA–DR antigens. Immunogenetics 19:109–115

    Article  PubMed  CAS  Google Scholar 

  22. Polak J, Van Noorden S (1983) Immunocytochemistry. Wright, Bristol

    Google Scholar 

  23. Harrist TJ, Ruiter DJ, Bhan AK, Mihm MC Jr (1983) The distribution of major histocompatibility antigens in normal skin. Br J Dermatol 109:623–633

    Article  PubMed  CAS  Google Scholar 

  24. Natali PG, Giacomini P, Russo C, Steinbach G, Fenoglio C, Ferrone S (1983) Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma–associated antigens. J Cutan Pathol 10:225–237

    Article  PubMed  CAS  Google Scholar 

  25. Poppema S, Bröcker EB, De Ley L, Terbrack D, Visscher T, Ter Haar A, Macher E, Thé HT, Sorg C (1983) In situ analysis of the mononuclear infiltrate in primary malignant melanoma of the skin. Clin Exp Immunol 51:77–82

    PubMed  CAS  Google Scholar 

  26. Ruiter DJ, Bergman W, Welvaart K, Scheffer E, Van Vloten WA, Russo C, Ferrone S (1984) Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res 44:3930–3935

    PubMed  CAS  Google Scholar 

  27. Kindt TJ, Mach B, Sogn JA, Robinson MA, Kulaga H, Möller E, Carlsson B, Wallin J, Bach FH (1984) Editorial review: identical or distinct functional roles for products of the HLA–DR, DC, and SB loci. Scand J Immunol 20:471–492

    Article  PubMed  CAS  Google Scholar 

  28. Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ (1984) Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human γ–in–terferon. J Exp Med 160:255–269

    Article  PubMed  CAS  Google Scholar 

  29. Pober JS, Gimbrone MA Jr (1982) Expression of Ia–like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci USA 79:6641–6645

    Article  PubMed  CAS  Google Scholar 

  30. Pober JS, Gimbrone MA Jr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA (1983) Ia expression by vascular endothelium is inducible by activated T cells and by human γ–interferon. J Exp Med 157:1339–1346

    Article  PubMed  CAS  Google Scholar 

  31. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA Jr, Strominger JL, Pober JS (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81:4917–4921

    Article  PubMed  CAS  Google Scholar 

  32. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB (1984) Recombinant gamma interferon induces HLA–DR expression on cultured human keratinocytes. J Invest Dermatol 83:88–93

    Article  PubMed  CAS  Google Scholar 

  33. Schwartz R, Momburg G, Moldenhauer G, Dörken B, Schirrmacher V (1985) Induction of HLA class–II antigen expression on human carcinoma cell lines by IFN–gamma. Int J Cancer 35:245–252

    Article  PubMed  CAS  Google Scholar 

  34. Koefler HP, Ranyard J, Yelton L, Billing R, Bohman R (1984) γ–Interferon induces expression of the HLA–D antigens on normal and leukemic human myeloid cells. Proc Natl Acad Sci USA 81:4080–4084; Cancer 35:245–252

    Article  Google Scholar 

  35. Kelley VE, Fiers W, Strom TB (1984) Cloned human interferon–γ, but not interferon –β or –α, induces expression of HLA–DR determinants by fetal monocytes and myeloid leukaemic cell lines. J Immunol 132:240–245

    PubMed  CAS  Google Scholar 

  36. Holzmann B, Johnson JP, Kandewitz P, Braun-Falco O, Riethmüller G (1984) Differential expression of antigens 15.75 and p3.58 on primary melanoma and benign nevi. Behring Inst Mitt 74:24–26

    PubMed  Google Scholar 

  37. Murphy GF, Bhan AK, Sato S, Harrist TJ, Mihm MC Jr (1981) Characterisation of Iangerhans cells by the use of monoclonal antibodies. Iab Invest 45:465–472

    CAS  Google Scholar 

  38. Bergman W, Willemze R, de Graaff-Reitsma C, Ruiter DJ (1985) Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. J Invest Dermatol 85:25–29

    Article  PubMed  CAS  Google Scholar 

  39. Ruiter DJ, Bergman W, Steylen PN, Scheffer E (1984) Histopathological aspects of dysplastic nevi. In: Ruiter DS, Welvaart K, Ferrone S (eds) Cutaneous melanoma and precursor lesions. Nijhoff, The Hague, The Netherlands, pp 239–248

    Chapter  Google Scholar 

  40. Van Duinen SG, Ruiter DJ, Bröcker EB, Sorg C, Welvaart K, Ferrone S (1984) Association of low level of HLA–A,B,C antigens on high level of Ia antigens in metastatic melanoma with a high grade of malignancy. J Invest Dermatol 82:558

    Google Scholar 

  41. Van Duinen SG, Ruiter DJ, Ferrone S (submitted) Expression of class II MHC antigens on freshly obtained melanoma cells in restricted mainly to cells which also express class I MHC antigens

    Google Scholar 

  42. Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C (1983) Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections. Cancer Immunol Immunother 16:53–58

    Article  PubMed  CAS  Google Scholar 

  43. Albino AP, Lloyd KO, Houghton AN, Oettgen HF, Old LJ (1981) Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma cells of the same patient. J Exp Med 154:1764–1778

    Article  PubMed  CAS  Google Scholar 

  44. Natali PG, Cavaliere R, Bigotti A, Nicotra MR, Russo C, Ng AK, Giacomini P, Ferrone S (1983) Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma. J Immunol 130:1462–1466

    PubMed  CAS  Google Scholar 

  45. Burchiel SW, Martin JC, Imai K, Ferrone S, Warner NL (1982) Heterogeneity of HLA–A,B, Ia–like, and melanoma–associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry. Cancer Res 42:4110–4115

    PubMed  CAS  Google Scholar 

  46. Sarkar S, Glassy MC, Ferrone S, Jones OW (1980) Cell cycle and the differential expression of HLA–A,B and HLA–DR antigens on human B lymphoid cells. Proc Natl Acad Sci USA 77:7297–7301

    Article  PubMed  CAS  Google Scholar 

  47. Fidler I J, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 197:893–897

    Article  Google Scholar 

  48. Pollack MS, Chin–Louid J, Moshief RD (1984) Functional characteristics and differential expression of class IIDR, DS, and SB antigens on human melanoma cell lines. Human Immunol 9:75–82

    Article  CAS  Google Scholar 

  49. Sell S (1978) Cancer markers: diagnostic and developmental significance. In: Waters H (ed) Handbook of cancer immunology, vol 3. Garland STPM, New York

    Google Scholar 

  50. Houghton AN, Eisinger M, Albino AP, Cairncross JG, Old LJ (1982) Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med 156:1755–1766

    Article  PubMed  CAS  Google Scholar 

  51. Fitchen JH, Foon KA, Cline MH (1981) The antigenic characteristics of hematopoietic stem cells. N Engl J Med 305:17–25

    Article  PubMed  CAS  Google Scholar 

  52. Pellegrino MA, Natali PG, Ng AK, Imai K, Russo C, Bigotti A, Wolf P, Ferrone S (1982) Unorthodox expression of Ia–like antigens on human tumor cells of nonlym–phoid origin: immunological properties, structural profile, significance and clinical relevance. In: Nakamura RM, Dito WR, Tucker ES (eds) Immunological analysis: recent progress in diagnostic Iaboratory immunology. Masson, New York, pp 159–173

    Google Scholar 

  53. Kornstein MJ, Brooks JSJ, Elder DE (1983) Immunoperoxidase localisation of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res 43:2749–2754

    PubMed  CAS  Google Scholar 

  54. Fossati G, Taramelli D, Dalsari A, Bogdanovich G, Andreola S, Parmiani G (1984) Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer 33:591–597

    Article  PubMed  CAS  Google Scholar 

  55. Guerry IV DP, Alexander MA, Herlyn MD, Zehngebot LM, Mitchell KF, Zmijewski CM, Lusk EJ (1984) HLA–DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. J Clin Invest 73:267–271

    Article  PubMed  Google Scholar 

  56. Taramelli D, Fossati G, Balsari A, Marolda R, Parmiani G (1984) The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA–DR antigens on the tumor cells. Int J Cancer 34:797–806

    Article  PubMed  CAS  Google Scholar 

  57. Gonwa TA, Picker LJ, Raff HV, Goyert SM, Silver J, Stobo JD (1983) Antigen–presenting capabilities of human monocytes correlates with their expression of HLA–DS, an Ia determinant distinct from HLA–DR. J Immunol 130:706–711

    PubMed  CAS  Google Scholar 

  58. McKean DJ, Infante AJ, Nilson A, Kimoto M, Fathman CG, Walker E, Warner N (1981) Major histocompatibility complex–restricted antigen presentation to antigen–reactive T cells by B lymphocyte tumor cells. J Exp Med 154:1419–1431

    Article  PubMed  CAS  Google Scholar 

  59. Glimchez LH, Kim KJ, Green I, Paul WE (1982) Ia antigen–bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex–restricted fashion to antigen–reactive T cells. J Exp Med 155:445–459

    Article  Google Scholar 

  60. Guy K, Van Heyningen V, Ziegler A, Steel MC (1984) Disparity in HLA–DC antigen expression on chronic lymphocytic leucaemia cells. Dis Markers 2:287–293

    Google Scholar 

  61. Faille A, Turmel P, Charron DJ (1984) Differential expression of HLA–DR and HLA–DC/DS molecules in a patient with hairy cell leukaemia: restoration of HLA–DC/DS expression by (12–0–tetradeconyl phorbol–13–acetate), 5–azacytidine, and sodium bu–tyrate. Blood 64:33–38

    PubMed  CAS  Google Scholar 

  62. Pellegrino MA, Ferrone S, Brautbar C, Hayflick L (1976) Changes in HLA antigen profiles on SV40 transformed human fibroblasts. Exp Cell Res 97:340

    Article  PubMed  CAS  Google Scholar 

  63. Janeway CA Jr, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay L, Murphy DB, Tite J (1984) Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today 5:99–105

    Article  CAS  Google Scholar 

  64. Van Duinen SG (1984) Pathobiologic and diagnostic aspects of human cutaneous melanoma. Thesis, Leiden; Kanters, Alblasserdam, Netherlands

    Google Scholar 

  65. Wilson BS, Imai K, Natali PG, Kay NE, Cavaliere R, Pellegrino MA, Ferrone S (1982) Immunochemical analysis of the antigenic profile of human melanoma cells with monoclonal antibodies. In: Reisfeld RA, Ferrone S (eds) Melanoma antigens and antibodies. Plenum, New York, pp 401–433

    Google Scholar 

  66. Alexander S, Hubbard SC, Strominger JL (1984) HLA–DR antigens of autologous melanoma and B lymphoblastoid cell lines: Differences in glycosylation but not protein structure. J Immunol 133:315–320

    PubMed  CAS  Google Scholar 

  67. Ashewell G, Morell AG (1977) Carbohydrates on class II major histocompatibility complex antigens may mediate carbohydrate–specific recognition. Trends Biochem Sci 2:76

    Article  Google Scholar 

  68. Wilson BS, Glassy MC, Quaranta V, Ng AK, Ferrone S (1981) Effect of tunicamycin on the assembly and antigenicity of HLA antigens: analysis with monoclonal antibodies. Scand J Immunol 14:201–205

    Article  PubMed  CAS  Google Scholar 

  69. Metzgar RS, Oleinick SR (1968) The study of normal and malignant cell antigens by mixed agglutination. Cancer Res 28:1366–1371

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. J. Ruiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. G. van Duinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Tsujisaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Ferrone
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Blood Bank and Immunohematological Laboratory, Rikshospitalet, National Hospital, Pilestredet 32, N-0027, Oslo 1, Norway

    Bjarte G. Solheim (Director) (Director)

  2. Karolinska Institute, Department of Clinical Immunology, Huddinge Hospital, S-14186, Huddinge, Sweden

    Erna Møller

  3. Dept. of Microbiology and Immunology, New York Medical College, Valhalla, NY, 10595, USA

    Soldano Ferrone

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ruiter, D.J., van Duinen, S.G., Tsujisaki, M., Ferrone, S. (1986). Class II HLA Antigens in Benign and Malignant Lesions of Melanocytic Origin. In: Solheim, B.G., Møller, E., Ferrone, S. (eds) HLA Class II Antigens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70367-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70367-6_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70369-0

  • Online ISBN: 978-3-642-70367-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation